Baylor College of Medicine News

Research News

New clinical study to focus on gut, autism connectionFeb 5, 2015
The connection between gastrointestinal problems and autism will be the focus of a new patient study led by Baylor College of Medicine and Texas Children’s Hospital.
Protect children’s skin from unregulated term 'hypoallergenic'Feb 4, 2015
Recent study finds two chemicals often associated with allergic reactions in many over-the-counter pediatric skin care products, including some labeled “hypoallergenic.”
Nanowafer technology more effective than topical eye dropsFeb 4, 2015
Researchers at Baylor have developed a nanowafer drug delivery system that is placed on the surface of the eye that contains arrays of drug-loaded nanoreservoirs.
Baylor College of Medicine and Miraca Holdings finalize joint venture on clinical genetic testingFeb 2, 2015
Join venture between Baylor College of Medicine and Miraca Holdings Inc. finalized for clinical genetics diagnostic laboratories.
Grant allows development of 'freeze-frame' proteins to study DNAJan 30, 2015
Baylor College of Medicine's Dr. Susan Rosenberg and colleagues awarded three-year $2 million grant from W.M. Keck Foundation.
Vitamin E protects against liver damage in parenterally fed premature pigsJan 27, 2015
Study finds adding vitamin E to lipid emulsions used to feed premature pigs intravenously prevents liver damage.
Evolution of marine mammals to water life converges in some genesJan 26, 2015
Baylor researchers contribute to study examining genomes of four marine mammals compared to their closest land kin to examine genetic evidence for convergent evolution.
Volunteers needed for colic studyJan 22, 2015
Volunteers wanted for a study to determine whether a probiotic can reduce the amount of crying and fussiness in infants with colic.
Baylor scientists identify a novel precursor to neurodegenerationJan 15, 2015
Researchers connect the presence of lipid droplet accumulation in the glia of specific mutants as a harbinger of neurodegeneration.
Better outcomes for treating deadly heart-related illnessJan 15, 2015
Baylor researchers contribute to a study that finds novel drugs provide better outcomes for non-valvular atrial fibrillation patients.